Revenue: The sum of all revenue fields included for a company's operating activities.
Sage Therapeutics, Inc. (SAGE) had Revenue of $14.06M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$14.06M |
$-62.21M |
|
$0.66M |
|
$13.41M |
|
$81.52M |
|
$-67.45M |
|
$5.24M |
|
$-62.21M |
|
$-62.21M |
|
$-62.21M |
|
$-62.21M |
|
$-62.21M |
|
$-62.21M |
|
$-67.45M |
|
$-68.32M |
|
61.86M |
|
61.86M |
|
$-1.01 |
|
$-1.01 |
|
| Balance Sheet Financials | |
$454.48M |
|
$0.78M |
|
$15.19M |
|
$469.67M |
|
$49.78M |
|
-- |
|
$10.04M |
|
$59.82M |
|
$409.85M |
|
$409.85M |
|
$409.85M |
|
62.54M |
|
| Cash Flow Statement Financials | |
$-81.73M |
|
$45.78M |
|
$0.15M |
|
$82.47M |
|
$46.67M |
|
$-35.80M |
|
$6.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.34% |
|
-479.66% |
|
-479.66% |
|
-- |
|
-442.39% |
|
-442.39% |
|
$-81.73M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
1.31 |
|
68.66 |
|
-15.18% |
|
-15.18% |
|
-13.25% |
|
-15.18% |
|
$6.55 |
|
$-1.32 |
|
$-1.32 |
|